Сторінка 1 від 20 результати
In this retrospective study, patch test results of 542 patients (303 female and 239 male), referred to our clinic between June 1996 and July 1999, were evaluated. All patients were patch tested with 32 allergens of an extended European standard series, 140 patients were tested with supplemental
BACKGROUND
Monitoring trends of positive patch test reactions is useful for epidemiological surveillance and contact allergy prevention, and has not previously been reported in Lithuania.
OBJECTIVE
To examine and compare changes in the prevalence of contact allergy to European baseline series
Allergic contact dermatitis (ACD) is a type IV delayed hypersensitivity reaction. During the last decade, there has been a heightened awareness of this disease in the pediatric population. The gold standard for diagnosis is patch testing. The prevalence of positive patch tests in referred children
OBJECTIVE
Patch testing is a standard diagnostic tool used in the identification of causative allergens in allergic contact dermatitis. Ongoing surveillance of rates of allergen positivity is vitally important to detect trends and allow comparisons between countries. The objective of this study was
The role of contact allergy in rosacea has rarely been investigated. In this retrospective study, 361 out of 76,697 patients tested and documented by the Information Network of Departments of Dermatology between 1995 and 2002 had rosacea. Patch tests included standard series and constituents of
Contact eczema (CE) is one of the most common skin diseases and is regarded as a reaction pattern. However, the skin can react in the same way to different stimuli, some of which may act together. The golden standard in the diagnosis of allergic contact dermatitis (ACD) is the patch test. Contact
BACKGROUND
Patch testing is an essential procedure in the investigation of eczema in children.
OBJECTIVE
To analyse the frequency of contact hypersensitivity and allergic contact dermatitis among Polish children with eczema.
METHODS
During an allergy screening programme involving 9320 children aged
Periorbital dermatitis is common and can be due to the external use of ophthalmic drugs. We evaluated patch test results of the Information Network of the Departments of Dermatology. During a 5-year period (1995-99), of a total 49,256 patch-tested patients, 1053 (2.1%) were eventually diagnosed as
Surveillance on common allergens identified by patch testing plays an important role in emerging allergen detection, which leads to both individual and societal level prevention.
To study the changes in the pattern of contact sensitization and to identify risk factors associated with allergens.
The
BACKGROUND
Patch testing is a diagnostic tool for the evaluation of patients with suspected allergic contact dermatitis. A standard series of allergens similar to that used by the North American Contact Dermatitis Group (NACDG) is used at Mayo Clinic.
OBJECTIVE
Our aim was to report the results of
BACKGROUND
The European Surveillance System on Contact Allergies (ESSCA) began in 2001 as project funded by a European Union grant to monitor and evaluate contact sensitization (CS) based on clinical data collected by participating European dermatology departments.
OBJECTIVE
ESSCA aims to detect
BACKGROUND
The North American Contact Dermatitis Group (NACDG) tests patients with suspected allergic contact dermatitis to a broad series of screening allergens and publishes periodic reports.
OBJECTIVE
The aims of this study were to report the NACDG patch-testing results from January 1, 2007, to
BACKGROUND
Patch testing is an important diagnostic tool for determination of substances responsible for allergic contact dermatitis.
OBJECTIVE
This study reports the North American Contact Dermatitis Group (NACDG) patch testing results from January 1, 2009, to December 31, 2010.
METHODS
At 12
OBJECTIVE
The objective of this study was to determine whether contact allergens play a role in chronic idiopathic urticaria (CIU).
METHODS
We conducted a longitudinal prospective study of 23 patients with CIU. Patients were patch tested to a modified North American Contact Dermatitis Group
Background: Prevalences of sensitivity to contact allergens change over time as a result of variations in allergen exposure.
Objectives: The aim of the study was to describe